Back to search
FDAFDA · Food and drugs·Recall number D-1286-2015

Mometasone Furoate Ointment USP, 0.1%, 15 g tubes, Rx Only, Manufactured by Perrigo, Yeruham 80500, Israel, Distributed by Perrigo, Allegan, MI 49010, NDC 45802-0119-37

Published August 12, 2015 · Recall initiated: July 13, 2015

Summary

FDA records drug Class III recall D-1286-2015, published August 12, 2015 and initiated July 13, 2015. Recalling firm: Perrigo Israel Pharmaceuticals; Status: Terminated; Reported quantity: 158,268 tubes; Lot: Lot # 063630, Exp 04/16; 069793, Exp 11/16; 071745, Exp 02/17; 076150, Exp 07/17; 081317, Exp 12/17. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent drug

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Perrigo Israel Pharmaceuticals
Distributor
Nationwide and Puerto Rico
Lot
Lot # 063630, Exp 04/16; 069793, Exp 11/16; 071745, Exp 02/17; 076150, Exp 07/17; 081317, Exp 12/17
Risk classification
Class III
Area (FDA)
drug
Country
Israel

Related recalls

Questions about this recall

Was Mometasone Furoate Ointment USP, 0.1%, 15 g tubes, Rx Only, Manufactured by Perrigo, Yeruham 80500, Israel, Distributed by Perrigo, Allegan, MI 49010, NDC 45802-0119-37 recalled?

Yes. FDA published recall D-1286-2015 on August 12, 2015. Reported hazard: Subpotent drug

What should I do if I have this product?

Voluntary: Firm initiated · Letter